Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
<p>Abstract</p> <p>Background</p> <p>Recent consensus guidelines recommend pregabalin as a first-tier treatment for painful diabetic peripheral neuropathy (DPN). We evaluated the efficacy of pregabalin 600 mg/d (300 mg dosed BID) versus placebo for relieving DPN-associa...
Main Authors: | LaMoreaux Linda, Rosenstock Julio, Arezzo Joseph C, Pauer Lynne |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | BMC Neurology |
Online Access: | http://www.biomedcentral.com/1471-2377/8/33 |
Similar Items
-
Addition of Celebrex and Pregabalin to Ropivacaine for Posterior Spinal Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial
by: Zhang Y, et al.
Published: (2021-02-01) -
Prophylactic use of pregabalin for prevention of succinylcholine-induced fasciculation and myalgia: a randomized, double-blinded, placebo-controlled study
by: Vinit K. Srivastava, et al.
Published: (2016-03-01) -
Prophylactic use of pregabalin for prevention of succinylcholine-induced fasciculation and myalgia: a randomized, double-blinded, placebo-controlled study
by: Vinit K. Srivastava, et al.
Published: (2016-04-01) -
To evaluate efficacy of pregabalin for the prevention of etomidate-induced myoclonus: A prospective, randomized, placebo-controlled, double-blind study
by: Vinit Kumar Srivastava, et al.
Published: (2021-01-01) -
Effect of Pregabalin on Perioperative Headache in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized Double-Blind, Placebo-Controlled Trial
by: Karen Ruby Lionel, et al.
Published: (2019-07-01)